Copyright Reports & Markets. All rights reserved.

Global H-Pylori Noninvasive Diagnostic Tests Market Research Report 2022

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global H-Pylori Noninvasive Diagnostic Tests Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
      • 1.2.2 Serology Test
      • 1.2.3 Stool Antigen Test
      • 1.2.4 Urea Breath Test
    • 1.3 Market by Application
      • 1.3.1 Global H-Pylori Noninvasive Diagnostic Tests Market Share by Application: 2017 VS 2021 VS 2028
      • 1.3.2 Hospitals
      • 1.3.3 Clinics
      • 1.3.4 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global H-Pylori Noninvasive Diagnostic Tests Market Perspective (2017-2028)
    • 2.2 H-Pylori Noninvasive Diagnostic Tests Growth Trends by Region
      • 2.2.1 H-Pylori Noninvasive Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028
      • 2.2.2 H-Pylori Noninvasive Diagnostic Tests Historic Market Size by Region (2017-2022)
      • 2.2.3 H-Pylori Noninvasive Diagnostic Tests Forecasted Market Size by Region (2023-2028)
    • 2.3 H-Pylori Noninvasive Diagnostic Tests Market Dynamics
      • 2.3.1 H-Pylori Noninvasive Diagnostic Tests Industry Trends
      • 2.3.2 H-Pylori Noninvasive Diagnostic Tests Market Drivers
      • 2.3.3 H-Pylori Noninvasive Diagnostic Tests Market Challenges
      • 2.3.4 H-Pylori Noninvasive Diagnostic Tests Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top H-Pylori Noninvasive Diagnostic Tests Players by Revenue
      • 3.1.1 Global Top H-Pylori Noninvasive Diagnostic Tests Players by Revenue (2017-2022)
      • 3.1.2 Global H-Pylori Noninvasive Diagnostic Tests Revenue Market Share by Players (2017-2022)
    • 3.2 Global H-Pylori Noninvasive Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Players Covered: Ranking by H-Pylori Noninvasive Diagnostic Tests Revenue
    • 3.4 Global H-Pylori Noninvasive Diagnostic Tests Market Concentration Ratio
      • 3.4.1 Global H-Pylori Noninvasive Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by H-Pylori Noninvasive Diagnostic Tests Revenue in 2021
    • 3.5 H-Pylori Noninvasive Diagnostic Tests Key Players Head office and Area Served
    • 3.6 Key Players H-Pylori Noninvasive Diagnostic Tests Product Solution and Service
    • 3.7 Date of Enter into H-Pylori Noninvasive Diagnostic Tests Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 H-Pylori Noninvasive Diagnostic Tests Breakdown Data by Type

    • 4.1 Global H-Pylori Noninvasive Diagnostic Tests Historic Market Size by Type (2017-2022)
    • 4.2 Global H-Pylori Noninvasive Diagnostic Tests Forecasted Market Size by Type (2023-2028)

    5 H-Pylori Noninvasive Diagnostic Tests Breakdown Data by Application

    • 5.1 Global H-Pylori Noninvasive Diagnostic Tests Historic Market Size by Application (2017-2022)
    • 5.2 Global H-Pylori Noninvasive Diagnostic Tests Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America H-Pylori Noninvasive Diagnostic Tests Market Size (2017-2028)
    • 6.2 North America H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2017-2022)
    • 6.3 North America H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe H-Pylori Noninvasive Diagnostic Tests Market Size (2017-2028)
    • 7.2 Europe H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2017-2022)
    • 7.3 Europe H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific H-Pylori Noninvasive Diagnostic Tests Market Size (2017-2028)
    • 8.2 Asia-Pacific H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America H-Pylori Noninvasive Diagnostic Tests Market Size (2017-2028)
    • 9.2 Latin America H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2017-2022)
    • 9.3 Latin America H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa H-Pylori Noninvasive Diagnostic Tests Market Size (2017-2028)
    • 10.2 Middle East & Africa H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa H-Pylori Noninvasive Diagnostic Tests Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 Sekisui Diagnostics
      • 11.1.1 Sekisui Diagnostics Company Detail
      • 11.1.2 Sekisui Diagnostics Business Overview
      • 11.1.3 Sekisui Diagnostics H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.1.4 Sekisui Diagnostics Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.1.5 Sekisui Diagnostics Recent Development
    • 11.2 Meridian Bioscience
      • 11.2.1 Meridian Bioscience Company Detail
      • 11.2.2 Meridian Bioscience Business Overview
      • 11.2.3 Meridian Bioscience H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.2.4 Meridian Bioscience Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.2.5 Meridian Bioscience Recent Development
    • 11.3 Bio-Rad Laboratories
      • 11.3.1 Bio-Rad Laboratories Company Detail
      • 11.3.2 Bio-Rad Laboratories Business Overview
      • 11.3.3 Bio-Rad Laboratories H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.3.4 Bio-Rad Laboratories Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.3.5 Bio-Rad Laboratories Recent Development
    • 11.4 Thermo Fisher Scientific
      • 11.4.1 Thermo Fisher Scientific Company Detail
      • 11.4.2 Thermo Fisher Scientific Business Overview
      • 11.4.3 Thermo Fisher Scientific H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.4.4 Thermo Fisher Scientific Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.4.5 Thermo Fisher Scientific Recent Development
    • 11.5 Alpha Laboratories
      • 11.5.1 Alpha Laboratories Company Detail
      • 11.5.2 Alpha Laboratories Business Overview
      • 11.5.3 Alpha Laboratories H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.5.4 Alpha Laboratories Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.5.5 Alpha Laboratories Recent Development
    • 11.6 Quidel
      • 11.6.1 Quidel Company Detail
      • 11.6.2 Quidel Business Overview
      • 11.6.3 Quidel H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.6.4 Quidel Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.6.5 Quidel Recent Development
    • 11.7 Cardinal Health
      • 11.7.1 Cardinal Health Company Detail
      • 11.7.2 Cardinal Health Business Overview
      • 11.7.3 Cardinal Health H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.7.4 Cardinal Health Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.7.5 Cardinal Health Recent Development
    • 11.8 FAN International
      • 11.8.1 FAN International Company Detail
      • 11.8.2 FAN International Business Overview
      • 11.8.3 FAN International H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.8.4 FAN International Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.8.5 FAN International Recent Development
    • 11.9 Sercon
      • 11.9.1 Sercon Company Detail
      • 11.9.2 Sercon Business Overview
      • 11.9.3 Sercon H-Pylori Noninvasive Diagnostic Tests Introduction
      • 11.9.4 Sercon Revenue in H-Pylori Noninvasive Diagnostic Tests Business (2017-2022)
      • 11.9.5 Sercon Recent Development

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Disclaimer

      Summary:

      Industry Insights
      The global H-Pylori Noninvasive Diagnostic Tests market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
      Fully considering the economic change by this health crisis, Serology Test accounting for % of the H-Pylori Noninvasive Diagnostic Tests global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
      China H-Pylori Noninvasive Diagnostic Tests market size is valued at US$ million in 2021, while the North America and Europe H-Pylori Noninvasive Diagnostic Tests are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe H-Pylori Noninvasive Diagnostic Tests landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global H-Pylori Noninvasive Diagnostic Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global H-Pylori Noninvasive Diagnostic Tests market in terms of revenue.
      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global H-Pylori Noninvasive Diagnostic Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global H-Pylori Noninvasive Diagnostic Tests market.
      Impact of Covid-19 Outbreak
      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
      Segmental Analysis
      The report has been segmented into product and application segments. The researchers have documented all the products present today in the H-Pylori Noninvasive Diagnostic Tests market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
      H-Pylori Noninvasive Diagnostic Tests Breakdown Data by Type
      Serology Test
      Stool Antigen Test
      Urea Breath Test
      H-Pylori Noninvasive Diagnostic Tests Breakdown Data by Application
      Hospitals
      Clinics
      Others
      Regional Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Nordic Countries
      Rest of Europe
      Asia-Pacific
      China
      Japan
      South Korea
      Southeast Asia
      India
      Australia
      Rest of Asia
      Latin America
      Mexico
      Brazil
      Rest of Latin America
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of MEA
      Competitive Landscape
      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
      Sekisui Diagnostics
      Meridian Bioscience
      Bio-Rad Laboratories
      Thermo Fisher Scientific
      Alpha Laboratories
      Quidel
      Cardinal Health
      FAN International
      Sercon
      Frequently Asked Questions
      What factors will challenge the H-Pylori Noninvasive Diagnostic Tests market growth?
      Which end-use segment will expand at the fastest CAGR in the H-Pylori Noninvasive Diagnostic Tests market?
      Which are the emerging players in the H-Pylori Noninvasive Diagnostic Tests market?
      How concentrated is the H-Pylori Noninvasive Diagnostic Tests market?
      Which factors are positively contributing to the H-Pylori Noninvasive Diagnostic Tests market growth?
      Which are the novel product innovations in the H-Pylori Noninvasive Diagnostic Tests market?
      Which product segment will emerge as the most lucrative in the H-Pylori Noninvasive Diagnostic Tests market?
      Which factors are increasing the competition in the H-Pylori Noninvasive Diagnostic Tests market?
      Which are the strategic measures taken by the H-Pylori Noninvasive Diagnostic Tests industry players?
      Which region will witness inactive growth during the forecast period?
      What key trends are likely to emerge in the H-Pylori Noninvasive Diagnostic Tests market in the coming years?

      Buy now